Last reviewed · How we verify
Rituximab, MTX, folic acid
Rituximab, MTX, folic acid is a Small molecule drug developed by Celltrion. It is currently in Phase 1 development. Also known as: Rituximab=CT-P10.
At a glance
| Generic name | Rituximab, MTX, folic acid |
|---|---|
| Also known as | Rituximab=CT-P10 |
| Sponsor | Celltrion |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma (EARLY_PHASE1)
- Mature B-Cell Lymphoma And Leukemia Study III (PHASE2, PHASE3)
- Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia (PHASE3)
- Tagraxofusp and Low-Intensity Chemotherapy for the Treatment of CD123 Positive Relapsed or Refractory Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma (PHASE1, PHASE2)
- Treatment of Rheumatoid Arthritis With DMARDs: Predictors of Response (PHASE3)
- Rituximab and Combination Chemotherapy in Treating Patients With Previously Untreated Mantle Cell Lymphoma (PHASE2)
- Ruxolitinib Phosphate or Dasatinib With Chemotherapy in Treating Patients With Relapsed or Refractory Philadelphia Chromosome-Like Acute Lymphoblastic Leukemia (PHASE2)
- DS-1594b With or Without Azacitidine, Venetoclax, or Mini-HCVD for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Rituximab, MTX, folic acid CI brief — competitive landscape report
- Rituximab, MTX, folic acid updates RSS · CI watch RSS
- Celltrion portfolio CI
Frequently asked questions about Rituximab, MTX, folic acid
What is Rituximab, MTX, folic acid?
Rituximab, MTX, folic acid is a Small molecule drug developed by Celltrion.
Who makes Rituximab, MTX, folic acid?
Rituximab, MTX, folic acid is developed by Celltrion (see full Celltrion pipeline at /company/celltrion).
Is Rituximab, MTX, folic acid also known as anything else?
Rituximab, MTX, folic acid is also known as Rituximab=CT-P10.
What development phase is Rituximab, MTX, folic acid in?
Rituximab, MTX, folic acid is in Phase 1.
Related
- Manufacturer: Celltrion — full pipeline
- Also known as: Rituximab=CT-P10
- Compare: Rituximab, MTX, folic acid vs similar drugs
- Pricing: Rituximab, MTX, folic acid cost, discount & access